(Q43225399)

16 November 2017

title

Performance of HbA(1c) for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing (English)

1 reference

16 November 2017

0 references

X H Zhou

1

1 reference

16 November 2017

L N Ji

2

1 reference

16 November 2017

Y Y Luo

3

1 reference

16 November 2017

X Y Zhang

4

1 reference

16 November 2017

X Y Han

5

1 reference

16 November 2017

Q Qiao

6

1 reference

16 November 2017

publication date

1 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

26

1 reference

16 November 2017

issue

12

1 reference

16 November 2017

page(s)

1262-1268

1 reference

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Understanding diagnostic tests 3: Receiver operating characteristic curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Utility of A1C for diabetes screening in the 1999 2004 NHANES population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Projected impact of implementing the results of the diabetes prevention program in the U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

The natural history of impaired glucose tolerance in the Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02831.X

10.1111/J.1464-5491.2009.02831.X

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference